SERUM DICKKOPF-1 IS INCREASED AND CORRELATES WITH BONE MINERAL DENSITY IN PATIENTS WITH THALASSEMIA-INDUCED OSTEOPOROSIS. REDUCTION POST ZOLEDRONIC ACID ADMINISTRATION

被引：0
|
作者：
Voskaridou, E. [1 ]
Christoulas, D. [2 ]
Xirakia, C. [1 ]
Varvagiannis, K. [1 ]
Boutsikas, G. [2 ]
Terpos, E. [2 ]
机构：
[1] Laikon Gen Hosp, Thalassemia Ctr, Athens, Greece
[2] Gen AF Hosp, Dept Med Res, Athens, Greece
来源：
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL | 2008年 / 93卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
0900
引用
收藏
页码：357 / 357
页数：1
相关论文
共 24 条
  • [21] Post hoc analysis of a single IV infusion of zoledronic acid versus daily oral risedronate on lumbar spine bone mineral density in different subgroups with glucocorticoid-induced osteoporosis
    Roux, C.
    Reid, D. M.
    Devogelaer, J. -P.
    Saag, K.
    Lau, C. S.
    Reginster, J. -Y.
    Papanastasiou, P.
    Bucci-Rechtweg, C.
    Su, G.
    Sambrook, P. N.
    OSTEOPOROSIS INTERNATIONAL, 2012, 23 (03) : 1083 - 1090
  • [22] Post hoc analysis of a single IV infusion of zoledronic acid versus daily oral risedronate on lumbar spine bone mineral density in different subgroups with glucocorticoid-induced osteoporosis
    C. Roux
    D. M. Reid
    J.-P. Devogelaer
    K. Saag
    C. S. Lau
    J.-Y. Reginster
    P. Papanastasiou
    C. Bucci-Rechtweg
    G. Su
    P. N. Sambrook
    Osteoporosis International, 2012, 23 : 1083 - 1090
  • [23] Effect of a Single 5-mg Infusion of Zoledronic Acid on Bone Turnover Markers Versus Oral Risedronate (5 mg/day) Over 1 Year in Patients with Glucocorticoid-Induced Osteoporosis.
    Sambrook, P.
    Devogelaer, J.
    Reginster, J.
    Saag, K.
    Roux, C.
    Lau, C.
    Papanastasiou, P.
    Schoenborn-Kellenberger, O.
    Maylandt, K.
    Fashola, T.
    Mesenbrink, P.
    Reid, D.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2008, 23 : S464 - S464
  • [24] Effect of a Single Infusion of Zoledronic Acid 5 mg versus Oral Risedronate 5 mg on Bone Mineral Density at Lumbar Spine, Hip, Femoral Neck and Trochanter in Patients with Glucocorticorid-Induced Osteoporosis
    Reid, D. M.
    Devogelaer, J.
    Saag, K.
    Roux, C.
    Lau, C. S.
    Reginster, J.
    Papanastasiou, P.
    Ferreira, A.
    Hartl, F.
    Fashola, T.
    Mesenbrink, P.
    Sambrook, P.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2008, 23 : S122 - S122
123